Review of Drug Repositioning Approaches and Resources
暂无分享,去创建一个
Jie Li | Yadong Wang | Haozhe Xie | Hanqing Xue | Yadong Wang | Jie Li | Haozhe Xie | Hanqing Xue
[1] Marko Bajec,et al. Unfolding communities in large complex networks: Combining defensive and offensive label propagation for core extraction , 2011, Physical review. E, Statistical, nonlinear, and soft matter physics.
[2] Ambuj K. Singh,et al. RRW: repeated random walks on genome-scale protein networks for local cluster discovery , 2009, BMC Bioinformatics.
[3] Xin Chen,et al. DCDB: Drug combination database , 2010, Bioinform..
[4] David Page,et al. A Simple Text Mining Approach for Ranking Pairwise Associations in Biomedical Applications , 2017, CRI.
[5] Dik-Lung Ma,et al. Drug repositioning by structure-based virtual screening. , 2013, Chemical Society reviews.
[6] Sean Ekins,et al. The Collaborative Drug Discovery (CDD) database. , 2013, Methods in molecular biology.
[7] R A Knight,et al. DRUGSURV: a resource for repositioning of approved and experimental drugs in oncology based on patient survival information , 2014, Cell Death and Disease.
[8] Seungmin Kang,et al. Drug Repositioning for Cancer Therapy Based on Large-Scale Drug-Induced Transcriptional Signatures , 2016, PloS one.
[9] Yanli Wang,et al. PubChem: Integrated Platform of Small Molecules and Biological Activities , 2008 .
[10] Damian Szklarczyk,et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored , 2010, Nucleic Acids Res..
[11] Marti A. Hearst. Untangling Text Data Mining , 1999, ACL.
[12] Lin Gao,et al. Detecting Overlapping Protein Complexes by Rough-Fuzzy Clustering in Protein-Protein Interaction Networks , 2014, PloS one.
[13] Alan F. Scott,et al. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders , 2002, Nucleic Acids Res..
[14] Bin Chen,et al. Chem2Bio2RDF: a semantic framework for linking and data mining chemogenomic and systems chemical biology data , 2010, BMC Bioinformatics.
[15] W. Alkema,et al. Application of text mining in the biomedical domain. , 2015, Methods.
[16] Luonan Chen,et al. Network-based drug repositioning. , 2013, Molecular bioSystems.
[17] Lei Chen,et al. Identification of new candidate drugs for lung cancer using chemical–chemical interactions, chemical–protein interactions and a K-means clustering algorithm , 2016, Journal of biomolecular structure & dynamics.
[18] Tudor I Oprea,et al. Computational and Practical Aspects of Drug Repositioning. , 2015, Assay and drug development technologies.
[19] Cheng Zhu,et al. Drug repositioning for orphan diseases , 2011, Briefings Bioinform..
[20] T. Ashburn,et al. Drug repositioning: identifying and developing new uses for existing drugs , 2004, Nature Reviews Drug Discovery.
[21] Xiang Zhang,et al. Drug repositioning by integrating target information through a heterogeneous network model , 2014, Bioinform..
[22] José Luís Oliveira,et al. BeCAS: biomedical concept recognition services and visualization , 2013, Bioinform..
[23] Zhiwei Cao,et al. Combining genomic and network characteristics for extended capability in predicting synergistic drugs for cancer , 2015, Nature Communications.
[24] Thomas C. Rindflesch,et al. EDGAR: extraction of drugs, genes and relations from the biomedical literature. , 1999, Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing.
[25] Roded Sharan,et al. Associating Genes and Protein Complexes with Disease via Network Propagation , 2010, PLoS Comput. Biol..
[26] W. Welsh,et al. Identification of Nitazoxanide as a Group I Metabotropic Glutamate Receptor Negative Modulator for the Treatment of Neuropathic Pain: An In Silico Drug Repositioning Study , 2015, Pharmaceutical Research.
[27] David S. Wishart,et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..
[28] Dmitrij Frishman,et al. MIPS: a database for protein sequences and complete genomes , 1998, Nucleic Acids Res..
[29] Sean R. Davis,et al. NCBI GEO: archive for functional genomics data sets—update , 2012, Nucleic Acids Res..
[30] D. Swinney,et al. How were new medicines discovered? , 2011, Nature Reviews Drug Discovery.
[31] H. Hermeking,et al. The MYC oncogene as a cancer drug target. , 2003, Current cancer drug targets.
[32] Yi Pan,et al. Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm , 2016, Bioinform..
[33] Akhilesh Pandey,et al. Human Protein Reference Database and Human Proteinpedia as Discovery Resources for Molecular Biotechnology , 2011, Molecular biotechnology.
[34] Lars Juhl Jensen,et al. EXTRACT 2.0: text-mining-assisted interactive annotation of biomedical named entities and ontology terms , 2017, bioRxiv.
[35] Jun Zou,et al. Advanced Systems Biology Methods in Drug Discovery and Translational Biomedicine , 2013, BioMed research international.
[36] M. Schuemie,et al. Anni 2.0: a multipurpose text-mining tool for the life sciences , 2008, Genome Biology.
[37] D. Kuter. New thrombopoietic growth factors. , 2007, Blood.
[38] Yanli Wang,et al. PubChem: a public information system for analyzing bioactivities of small molecules , 2009, Nucleic Acids Res..
[39] Nasser Ghadiri,et al. A review of network‐based approaches to drug repositioning , 2018, Briefings Bioinform..
[40] Sophia Ananiadou,et al. Discovering and visualizing indirect associations between biomedical concepts , 2011, Bioinform..
[41] Jaehoon Choi,et al. BEST: Next-Generation Biomedical Entity Search Tool for Knowledge Discovery from Biomedical Literature , 2016, PloS one.
[42] P. DeotarseP.,et al. Drug Repositioning: A Review , 2015 .
[43] David S. Wishart,et al. Nucleic Acids Research Polysearch: a Web-based Text Mining System for Extracting Relationships between Human Diseases, Genes, Mutations, Drugs Polysearch: a Web-based Text Mining System for Extracting Relationships between Human Diseases, Genes, Mutations, Drugs and Metabolites , 2008 .
[44] Dimitrios Gunopulos,et al. Automatic subspace clustering of high dimensional data for data mining applications , 1998, SIGMOD '98.
[45] Gerold Schmitt-Ulms,et al. Drug Repositioning for Alzheimer’s Disease Based on Systematic ‘omics’ Data Mining , 2016, PloS one.
[46] Susumu Goto,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..
[47] J. Delvenne,et al. Random walks on graphs , 2004 .
[48] Martin Serrano,et al. Nucleic Acids Research Advance Access published October 18, 2007 ChemBank: a small-molecule screening and , 2007 .
[49] A. Persidis,et al. Literature analysis for systematic drug repurposing: a case study from Biovista , 2011 .
[50] Alfonso Valencia,et al. Text-mining approaches in molecular biology and biomedicine. , 2005, Drug discovery today.
[51] Julio Saez-Rodriguez,et al. DvD: An R/Cytoscape pipeline for drug repurposing using public repositories of gene expression data , 2012, Bioinform..
[52] Archana Agarwal,et al. Zebrafish screen identifies novel compound with selective toxicity against leukemia. , 2012, Blood.
[53] Alexander E. Ivliev,et al. Drug Target Prediction and Repositioning Using an Integrated Network-Based Approach , 2013, PloS one.
[54] Esha T Shah,et al. Repositioning “old” drugs for new causes: identifying new inhibitors of prostate cancer cell migration and invasion , 2016, Clinical & Experimental Metastasis.
[55] Adam E. Hendry,et al. Chemical genetics and drug discovery in Xenopus. , 2012, Methods in molecular biology.
[56] Ulf Leser,et al. ALIBABA: PubMed as a graph , 2006, Bioinform..
[57] Nada Lavrac,et al. TextFlows: A visual programming platform for text mining and natural language processing , 2016, Sci. Comput. Program..
[58] G J Williams,et al. The Protein Data Bank: a computer-based archival file for macromolecular structures. , 1978, Archives of biochemistry and biophysics.
[59] Georgios A. Pavlopoulos,et al. DrugQuest - a text mining workflow for drug association discovery , 2016, BMC Bioinformatics.
[60] J. Fields,et al. Non-Peptide Arginine-Vasopressin Antagonists (Vaptans) for the Treatment of Hyponatremia in Neurocritical Care: A New Alternative? , 2009, Neurocritical care.
[61] David J. Porteous,et al. Speeding disease gene discovery by sequence based candidate prioritization , 2005, BMC Bioinformatics.
[62] Hans-Peter Kriegel,et al. OPTICS: ordering points to identify the clustering structure , 1999, SIGMOD '99.
[63] R. P. van de Riet,et al. Applications of Natural Language to Information Systems , 1996 .
[64] Delbert Dueck,et al. Clustering by Passing Messages Between Data Points , 2007, Science.
[65] Jaime Prilusky,et al. Proteopedia - a scientific 'wiki' bridging the rift between three-dimensional structure and function of biomacromolecules , 2008, Genome Biology.
[66] Benjamin N. Roin. Unpatentable Drugs and the Standards of Patentability , 2009 .
[67] Guillermo Palma,et al. Drug-Target Interaction Prediction Using Semantic Similarity and Edge Partitioning , 2014, SEMWEB.
[68] Mehmet Gönen,et al. Predicting drug-target interactions from chemical and genomic kernels using Bayesian matrix factorization , 2012, Bioinform..
[69] Hongfang Liu,et al. A new method for prioritizing drug repositioning candidates extracted by literature-based discovery , 2015, 2015 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).
[70] Salvador Ventura,et al. Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity , 2016, Nature Communications.
[71] David L. Wheeler,et al. GenBank , 2015, Nucleic Acids Res..
[72] Pierre Baldi,et al. ChemDB: a public database of small molecules and related chemoinformatics resources , 2005, Bioinform..
[73] Chee Keong Kwoh,et al. Drug-target interaction prediction by learning from local information and neighbors , 2013, Bioinform..
[74] Lin Gao,et al. Inferring drug-disease associations based on known protein complexes , 2015, BMC Medical Genomics.
[75] P. Stouten,et al. Identification of phosphorylase kinase as a novel therapeutic target through high-throughput screening for anti-angiogenesis compounds in zebrafish , 2012, Oncogene.
[76] Giup Jang,et al. Literature-based prediction of novel drug indications considering relationships between entities. , 2017, Molecular bioSystems.
[77] Tiziana di Matteo,et al. Graph Theory Enables Drug Repurposing – How a Mathematical Model Can Drive the Discovery of Hidden Mechanisms of Action , 2013, PloS one.
[78] Mingyao Liu,et al. Zebrafish cancer and metastasis models for in vivo drug discovery. , 2013, Drug discovery today. Technologies.
[79] Chao Wu,et al. Computational drug repositioning through heterogeneous network clustering , 2013, BMC Systems Biology.
[80] Yan Zhao,et al. Drug repositioning: a machine-learning approach through data integration , 2013, Journal of Cheminformatics.
[81] Xiaoyan Zhu,et al. Building Disease-Specific Drug-Protein Connectivity Maps from Molecular Interaction Networks and PubMed Abstracts , 2009, PLoS Comput. Biol..
[82] I. Tannock,et al. A critical appraisal of the "human tumor stem-cell assay". , 1983, The New England journal of medicine.
[83] Tudor I. Oprea,et al. Drug Repurposing from an Academic Perspective. , 2011, Drug discovery today. Therapeutic strategies.
[84] A. Barabasi,et al. Network medicine : a network-based approach to human disease , 2010 .
[85] M. Höglund,et al. Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia , 2015, Blood Cancer Journal.
[86] Isabel Moreno,et al. MaNER: A MedicAl Named Entity Recogniser , 2015, NLDB.
[87] Armando Blanco,et al. DrugNet: Network-based drug-disease prioritization by integrating heterogeneous data , 2015, Artif. Intell. Medicine.
[88] Hans-Peter Kriegel,et al. Density-Based Clustering in Spatial Databases: The Algorithm GDBSCAN and Its Applications , 1998, Data Mining and Knowledge Discovery.
[89] Peter Woollard,et al. An Integrated Data Driven Approach to Drug Repositioning Using Gene-Disease Associations , 2016, PloS one.
[90] Stephen T. C. Wong,et al. DrugMap Central: an on-line query and visualization tool to facilitate drug repositioning studies , 2013, Bioinform..
[91] Cui Tao,et al. Exploring the Pharmacogenomics Knowledge Base (PharmGKB) for Repositioning Breast Cancer Drugs by Leveraging Web Ontology Language (OWL) and Cheminformatics Approaches , 2013, Pacific Symposium on Biocomputing.
[92] Jiong Yang,et al. STING: A Statistical Information Grid Approach to Spatial Data Mining , 1997, VLDB.
[93] P. Robinson,et al. Walking the interactome for prioritization of candidate disease genes. , 2008, American journal of human genetics.
[94] Bin Chen,et al. Assessing Drug Target Association Using Semantic Linked Data , 2012, PLoS Comput. Biol..
[95] Hiroyuki Ogata,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..
[96] John P. Overington,et al. ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..
[97] Seong-Hoon Park,et al. Effect of combined treatment with progesterone and tamoxifen on the growth and apoptosis of human ovarian cancer cells. , 2011, Oncology reports.
[98] Russ B Altman,et al. PharmGKB: the Pharmacogenomics Knowledge Base. , 2013, Methods in molecular biology.
[99] Marc Weeber,et al. Using concepts in literature-based discovery: Simulating Swanson's Raynaud-fish oil and migraine-magnesium discoveries , 2001, J. Assoc. Inf. Sci. Technol..
[100] Igor Jurisica,et al. Protein complex prediction via cost-based clustering , 2004, Bioinform..
[101] Sanghyun Park,et al. Protein localization vector propagation: a method for improving the accuracy of drug repositioning. , 2015, Molecular bioSystems.